Homoeopathic versus Conventional Therapy for Atopic Eczema in Children: Medical and Economic Results

Background: One of five children visiting a homoeopathic physician is suffering from atopic eczema. Objective: To examine the effectiveness, safety and costs of homoeopathic versus conventional treatment in usual care. Methods: In a prospective multicentre comparative observational non-randomised study, 135 children (homoeopathy n = 48 vs. conventional n = 87) with mild to moderate atopic eczema were included. The primary outcome was the SCORAD (Scoring Atopic Dermatitis) at 6 months. Further outcomes at 6 and 12 months also included quality of life of parents and children, use of conventional medicine, treatment safety and disease-related costs. Results: The adjusted SCORAD showed no significant differences between the groups at both 6 months (homoeopathy 22.49 ± 3.02 [mean ± SE] vs. conventional 18.20 ± 2.31, p = 0.290) and 12 months (17.41 ± 3.01 vs. 17.29 ± 2.31, p = 0.974). Adjusted costs were higher in the homoeopathic than in the conventional group: for the first 6 months EUR 935.02 vs. EUR 514.44, p = 0.026, and for 12 months EUR 1,524.23 vs. EUR 721.21, p = 0.001. Quality of life was not significantly different between both groups. Conclusion: Taking patient preferences into account, homoeopathic treatment was not superior to conventional treatment for children with mild to moderate atopic eczema.

[1]  G. Varigos,et al.  Atopic eczema: its impact on the family and financial cost , 1997, Archives of disease in childhood.

[2]  J. Ring,et al.  [Cost-of-illness study in patients suffering from atopic eczema in Germany]. , 2005, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[3]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.

[4]  U. Wahn,et al.  Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial , 2006, BMJ : British Medical Journal.

[5]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[6]  R. Prescott,et al.  The cost of atopic eczema , 1996, The British journal of dermatology.

[7]  H. Williams,et al.  What are the best outcome measurements for atopic eczema? A systematic review. , 2007, The Journal of allergy and clinical immunology.

[8]  L. Buys,et al.  Treatment options for atopic dermatitis. , 2007, American family physician.

[9]  D. Strachan,et al.  Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. , 1999, The Journal of allergy and clinical immunology.

[10]  Thomas A Luger,et al.  Consensus conference on pediatric atopic dermatitis. , 2003, Journal of the American Academy of Dermatology.

[11]  M. Barbeau,et al.  Burden of Atopic dermatitis in Canada , 2006, International journal of dermatology.

[12]  H. Wichmann,et al.  Alternative medicine in allergies – prevalence, patterns of use, and costs , 2002, Allergy.

[13]  Wayne B Jonas,et al.  Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials , 1997, The Lancet.

[14]  D. Bottigioli,et al.  Tolerance of Oat-Based Topical Products in Cereal-Sensitized Adults with Atopic Dermatitis , 2009, Dermatology.

[15]  H. Williams,et al.  How atopic is atopic dermatitis? , 2004, The Journal of allergy and clinical immunology.

[16]  J. Ring,et al.  Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. , 1997, Dermatology.

[17]  U. Wahn,et al.  Entwicklung und Validierung eines krankheitsspezifischen Fragebogens zur Erfassung der Lebensqualität von Eltern neurodermitiskranker Kinder , 1999, Zeitschrift für Gesundheitswissenschaften = Journal of public health.

[18]  K. Schäkel,et al.  Treatment Following an Evidence-Based Algorithm versus Individualised Symptom-Oriented Treatment for Atopic Eczema , 2008, Dermatology.

[19]  S. Willich,et al.  Homeopathic medical practice: Long-term results of a cohort study with 3981 patients , 2005, BMC public health.

[20]  F. Rutten,et al.  The cost of atopic dermatitis in the Netherlands: an international comparison , 2002, The British journal of dermatology.

[21]  G V Wilson,et al.  Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. , 1991, Journal of psychosomatic research.

[22]  Jon Adams,et al.  Complementary and alternative medicine therapies in acne, psoriasis, and atopic eczema: results of a qualitative study of patients' experiences and perceptions. , 2006, Journal of alternative and complementary medicine.

[23]  S. Willich,et al.  Homoeopathic versus conventional treatment of children with eczema: a comparative cohort study. , 2008, Complementary therapies in medicine.

[24]  T. Werfel,et al.  The incidence of atopic dermatitis in school entrants is associated with individual life‐style factors but not with local environmental factors in Hannover, Germany , 2002, The British journal of dermatology.

[25]  H. Williams,et al.  What is the cost of atopic dermatitis in preschool children? , 2001, The British journal of dermatology.

[26]  P G Mulder,et al.  Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. , 1999, Acta dermato-venereologica.

[27]  S. Willich,et al.  Diagnoses and Treatment in Homeopathic Medical Practice , 2004, Complementary Medicine Research.

[28]  A. Kemp.  Atopic eczema: Its social and financial costs , 1999, Journal of paediatrics and child health.

[29]  A Y Finlay,et al.  The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use , 1995, The British journal of dermatology.

[30]  J. Ring,et al.  Krankheitskostenstudie bei Patienten mit atopischem Ekzem in Deutschland , 2005, Der Hautarzt.

[31]  D. Strachan,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis II. Observer variation of clinical diagnosis and signs of atopic dermatitis , 1994, The British journal of dermatology.

[32]  L. Hedges,et al.  Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. , 1997, Lancet.

[33]  S. Willich,et al.  Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. , 2005, Complementary therapies in medicine.

[34]  A. Ehlers,et al.  Cost evaluation in atopic eczema , 1999 .

[35]  C. R. Daniel,et al.  Cost of atopic dermatitis and eczema in the United States. , 2001, Journal of the American Academy of Dermatology.

[36]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .